Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid ...

As if you needed another reason to drink water, staying hydrated every day will do wonders for the gut microbiome. Dominguez ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Damaged mitochondria are recycled within cells. Scientists find a link between cellular health and diseases like Parkinson’s ...

The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...

They also map sites of cholesterol high occupancy and residence time on active versus inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD ... associated with other changes in plasma ...

Are you left-handed or right-handed? Most people are right-handed, and only about 10 percent of the population is left-handed ...

Scientists in Japan have uncovered a surprising twist, literally, in how molecules organize themselves. By introducing tiny leftover fragments from previous assemblies, they discovered a way to flip ...

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

It's a surprisingly tricky question: the body's glycemic response to different foods varies based on individual genetics, microbiomes, hormonal fluctuations, and more. Because of that, providing ...